Pharmacological Modulators of Sphingolipid Metabolism for the Treatment of Cystic Fibrosis Lung Inflammation
None
Saved in:
| Main Authors: | Dechecchi, M.C., Nicolis, E., Mazzi, P., Paroni, M., Cioffi, F., Tamanini, A., Bezzerri, V., Tebon, M., Lampronti, I., Huang, S., Wiszniewski, L., Scupoli, M.T., Bragonzi, A., Gambari, R., Berton, G., Cabrini, G. |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2012
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/34293 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Bioactive Sphingolipids in Neuroblastoma
by: Rahmaniyan, Mehrdad, et al.
Published: (2012) -
Pharmacological Potential of PDE5 Inhibitors for the Treatment of Cystic Fibrosis
by: Lubamba, Bob, et al.
Published: (2012) -
Cystic Fibrosis and Infertility
by: Batitucci, Maria do Carmo Pimentel, et al.
Published: (2012) -
Tandem Mass Spectrometry of Sphingolipids: Application in Metabolic Studies and Diagnosis of Inherited Disorders of Sphingolipid Metabolism
by: Kuchař, Ladislav, et al.
Published: (2012) -
Effect of cystic fibrosis transmembrane conductance regulator modulators and dedicated cystic fibrosis gastrointestinal clinic visits on the incidence of distal intestinal obstructive syndrome in persons with cystic fibrosis.
by: Nicha Wongjarupong, et al.
Published: (2025-01-01)


